EXPRS2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ExpreS2ion Biotech Holding AB

Watchlist Manager

Watchlist

Price: 1.605 SEK -0.93% Market Closed

Market Cap: kr37.6m

E	ExpreS2ion Biotech Holding AB STO:EXPRS2	SE
	Liberty Media Corp OTC:LLYVB	US
	Vesuvius PLC LSE:VSVS	UK
	Profound Medical Corp TSX:PRN	CA
	Wheels Up Experience Inc NYSE:UP	US
	Divi's Laboratories Ltd NSE:DIVISLAB	IN

Profitability Summary

ExpreS2ion Biotech Holding AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

71%

Negative 3Y Average Gross Margin

-63%

Gross Margin is Increasing

-209% > 71%

Negative Operating Margin

-363%

Negative 3Y Average Operating Margin

-877%

Operating Margin is Increasing

-2.145% > -363%

Negative Net Margin

-312%

Negative 3Y Average Net Margin

-650%

Net Margin is Increasing

-1.968% > -312%

Negative Free Cash Flow Margin

-335%

Negative 3Y Average Free Cash Flow Margin

-818%

Free Cash Flow Margin is Increasing

-1.884% > -335%

Negative ROE

-76%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-327%

ROIC is Increasing

-763% > -269%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.